Literature DB >> 26909707

If Channel Inhibition With Ivabradine Does Not Improve Cardiac and Vascular Function in Experimental Septic Shock.

Chaojie Wei1, Narimane Al Kattani, Huguette Louis, Eliane Albuisson, Bruno Levy, Antoine Kimmoun.   

Abstract

OBJECTIVE: Previous studies have suggested that lowering heart rate (HR) by selective β1-blockers improves sepsis-induced cardiac and vascular dysfunction primarily by decreasing proinflammatory pathways. However, the impact of isolated heart rate reduction (HRR) on hemodynamics and inflammatory pathways remains unknown. The present study was designed to assess the effects of HRR by ivabradine, an If channel inhibitor, on cardiovascular function and inflammatory pathways in peritonitis-induced septic shock in rats.
DESIGN: Randomized animal study.
SETTING: University research laboratory.
INTERVENTIONS: Four hours after cecal ligation and puncture (CLP), Wistar rats were randomly allocated to the following groups: CLP (n = 8) and CLP + ivabradine (n = 8, administered per os 4 h after the surgery). Another eight Wistar male rats underwent sham operation. All rats received a continuous infusion of saline (10 mL kg h), analgesic (nalbuphine: 0.2 mg kg h), and antibiotics (imipenem and cilastatin sodium: 10 mg kg) 4 h after the surgery. Assessment at 18 h included hemodynamics, in vivo cardiac function by echocardiography, and ex vivo vasoreactivity by myography. Circulating cytokine levels (TNF-α, IL-6, and IL-10) were measured by ELISA, whereas cardiac and vascular protein expressions of NF-κB/IκBα/iNOS and Akt/eNOS were assessed by Western blotting.
RESULTS: Compared with sham animals, CLP induced tachycardia, hypotension, decreased cardiac output, hyperlactatemia, and vascular hyporesponsiveness to vasopressors. Compared with the CLP group, adjunction of ivabradine decreased the HR without any impact on blood pressure, lactatemia, or vascular responsiveness to vasopressors. Adjunction of ivabradine to CLP rats had no impact on TNF-α, IL-6, and IL-10 cytokines, or on the protein expression levels of phosphorylated forms of NF-κB, Akt, eNOS, and degradation of IκBα in cardiac and vascular tissues.
CONCLUSION: Isolated HRR by ivabradine in an experimental model of septic shock does not appear to be associated with any effect on the tested parameters of cardiac function or on vascular responsiveness to vasopressors. Moreover, in this setting, ivabradine does not alter the circulating levels of selected pro/anti-inflammatory cytokines or cardiac and vascular NF-κB/IκBα protein expression levels.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26909707     DOI: 10.1097/SHK.0000000000000593

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  5 in total

Review 1.  Sinus Tachycardia: a Multidisciplinary Expert Focused Review.

Authors:  Kenneth A Mayuga; Artur Fedorowski; Fabrizio Ricci; Rakesh Gopinathannair; Jonathan Walter Dukes; Christopher Gibbons; Peter Hanna; Dan Sorajja; Mina Chung; David Benditt; Robert Sheldon; Mirna B Ayache; Hiba AbouAssi; Kalyanam Shivkumar; Blair P Grubb; Mohamed H Hamdan; Stavros Stavrakis; Tamanna Singh; Jeffrey J Goldberger; James A S Muldowney; Mark Belham; David C Kem; Cem Akin; Barbara K Bruce; Nicole E Zahka; Qi Fu; Erik H Van Iterson; Satish R Raj; Fetnat Fouad-Tarazi; David S Goldstein; Julian Stewart; Brian Olshansky
Journal:  Circ Arrhythm Electrophysiol       Date:  2022-09-08

Review 2.  The autonomic nervous system in septic shock and its role as a future therapeutic target: a narrative review.

Authors:  Marta Carrara; Manuela Ferrario; Bernardo Bollen Pinto; Antoine Herpain
Journal:  Ann Intensive Care       Date:  2021-05-17       Impact factor: 6.925

3.  Effects of low doses of esmolol on cardiac and vascular function in experimental septic shock.

Authors:  Chaojie Wei; Huguette Louis; Margaux Schmitt; Eliane Albuisson; Sophie Orlowski; Bruno Levy; Antoine Kimmoun
Journal:  Crit Care       Date:  2016-12-21       Impact factor: 9.097

4.  Heart Rate in Patients with SARS-CoV-2 Infection: Prevalence of High Values at Discharge and Relationship with Disease Severity.

Authors:  Alessandro Maloberti; Nicola Ughi; Davide Paolo Bernasconi; Paola Rebora; Iside Cartella; Enzo Grasso; Deborah Lenoci; Francesca Del Gaudio; Michela Algeri; Sara Scarpellini; Enrico Perna; Alessandro Verde; Caterina Santolamazza; Francesco Vicari; Maria Frigerio; Antonia Alberti; Maria Grazia Valsecchi; Claudio Rossetti; Oscar Massimiliano Epis; Cristina Giannattasio
Journal:  J Clin Med       Date:  2021-11-28       Impact factor: 4.241

5.  Assessment of hypertension and other factors associated with the severity of disease in COVID-19 pneumonia, Addis Ababa, Ethiopia: A case-control study.

Authors:  Andargew Yohannes Ashamo; Abebaw Bekele; Adane Petrose; Tsegaye Gebreyes; Eyob Kebede Etissa; Amsalu Bekele; Deborah Haisch; Neil W Schluger; Hanan Yusuf; Tewodros Haile; Negussie Deyessa; Dawit Kebede
Journal:  PLoS One       Date:  2022-08-15       Impact factor: 3.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.